Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis

Background and Aims: Acute-on-chronic liver failure (ACLF) is an acute deterioration of chronic liver disease with high short-term mortality. The inclusion or exclusion of previously decompensated cirrhosis (DC) in the diagnostic criteria of ACLF defined by the Asian Pacific Association for the Stud...

Full description

Bibliographic Details
Main Authors: Manman Xu, Ming Kong, Pengfei Yu, Yingying Cao, Fang Liu, Bing Zhu, Yizhi Zhang, Wang Lu, Huaibin Zou, Shaoli You, Shaojie Xin, Zhongping Duan, Tao Han, Yu Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.750061/full
_version_ 1818724539376336896
author Manman Xu
Manman Xu
Ming Kong
Ming Kong
Pengfei Yu
Pengfei Yu
Yingying Cao
Fang Liu
Bing Zhu
Yizhi Zhang
Yizhi Zhang
Wang Lu
Wang Lu
Huaibin Zou
Huaibin Zou
Shaoli You
Shaojie Xin
Zhongping Duan
Zhongping Duan
Tao Han
Yu Chen
Yu Chen
author_facet Manman Xu
Manman Xu
Ming Kong
Ming Kong
Pengfei Yu
Pengfei Yu
Yingying Cao
Fang Liu
Bing Zhu
Yizhi Zhang
Yizhi Zhang
Wang Lu
Wang Lu
Huaibin Zou
Huaibin Zou
Shaoli You
Shaojie Xin
Zhongping Duan
Zhongping Duan
Tao Han
Yu Chen
Yu Chen
author_sort Manman Xu
collection DOAJ
description Background and Aims: Acute-on-chronic liver failure (ACLF) is an acute deterioration of chronic liver disease with high short-term mortality. The inclusion or exclusion of previously decompensated cirrhosis (DC) in the diagnostic criteria of ACLF defined by the Asian Pacific Association for the Study of the Liver (APASL-ACLF) has not been conclusive. We aimed to evaluate the prognostic impact of decompensated cirrhosis in ACLF.Methods: We retrospectively collected a cohort of patients with a diagnosis of APASL-ACLF (with or without DC) hospitalized from 2012 to 2020 at three liver units in tertiary hospitals. Baseline characteristics and survival data at 28, 90, 180, 360, 540, and 720 days were collected.Results: Of the patients assessed using APASL-ACLF criteria without the diagnostic indicator of chronic liver disease, 689 patients were diagnosed with ACLF, of whom 435 had no decompensated cirrhosis (non-DC-ACLF) and 254 had previously decompensated cirrhosis (DC-ACLF). The 28-, 90-, 180-, 360-, 540-, and 720-day mortality were 24.8, 42.9, 48.7, 57.3, 63.4, and 68.1%, respectively, in DC-ACLF patients, which were significantly higher than in non-DC-ACLF patients (p < 0.05). DC was independently associated with long-term (180/360/540/720 days) but not short-term (28/90 days) mortality in patients with ACLF. Age, total bilirubin, international normalized ratio, and hepatic encephalopathy were independent risk factors for short- and long-term mortality risk in ACLF patients (p < 0.05).Conclusions: Patients with DC-ACLF have a higher mortality rate, especially long-term mortality, compared to non-DC-ACLF patients. Therefore, DC should be included in the diagnostic criteria of APASL-ACLF and treated according to the ACLF management process.
first_indexed 2024-12-17T21:28:01Z
format Article
id doaj.art-1fb61c2465274f8daf81fae7f634895f
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-17T21:28:01Z
publishDate 2021-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-1fb61c2465274f8daf81fae7f634895f2022-12-21T21:31:59ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-10-01810.3389/fmed.2021.750061750061Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated CirrhosisManman Xu0Manman Xu1Ming Kong2Ming Kong3Pengfei Yu4Pengfei Yu5Yingying Cao6Fang Liu7Bing Zhu8Yizhi Zhang9Yizhi Zhang10Wang Lu11Wang Lu12Huaibin Zou13Huaibin Zou14Shaoli You15Shaojie Xin16Zhongping Duan17Zhongping Duan18Tao Han19Yu Chen20Yu Chen21Fourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, ChinaBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, ChinaFourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, ChinaBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, ChinaFourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, ChinaBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, ChinaDepartment of Hepatology, Third Central Hospital of Tianjin, Tianjin, ChinaDepartment of Hepatology, Third Central Hospital of Tianjin, Tianjin, ChinaLiver Failure Treatment and Research Center, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, ChinaFourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, ChinaBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, ChinaFourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, ChinaBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, ChinaFourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, ChinaBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, ChinaLiver Failure Treatment and Research Center, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, ChinaLiver Failure Treatment and Research Center, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, ChinaFourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, ChinaBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, ChinaDepartment of Hepatology, Third Central Hospital of Tianjin, Tianjin, ChinaFourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, ChinaBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, ChinaBackground and Aims: Acute-on-chronic liver failure (ACLF) is an acute deterioration of chronic liver disease with high short-term mortality. The inclusion or exclusion of previously decompensated cirrhosis (DC) in the diagnostic criteria of ACLF defined by the Asian Pacific Association for the Study of the Liver (APASL-ACLF) has not been conclusive. We aimed to evaluate the prognostic impact of decompensated cirrhosis in ACLF.Methods: We retrospectively collected a cohort of patients with a diagnosis of APASL-ACLF (with or without DC) hospitalized from 2012 to 2020 at three liver units in tertiary hospitals. Baseline characteristics and survival data at 28, 90, 180, 360, 540, and 720 days were collected.Results: Of the patients assessed using APASL-ACLF criteria without the diagnostic indicator of chronic liver disease, 689 patients were diagnosed with ACLF, of whom 435 had no decompensated cirrhosis (non-DC-ACLF) and 254 had previously decompensated cirrhosis (DC-ACLF). The 28-, 90-, 180-, 360-, 540-, and 720-day mortality were 24.8, 42.9, 48.7, 57.3, 63.4, and 68.1%, respectively, in DC-ACLF patients, which were significantly higher than in non-DC-ACLF patients (p < 0.05). DC was independently associated with long-term (180/360/540/720 days) but not short-term (28/90 days) mortality in patients with ACLF. Age, total bilirubin, international normalized ratio, and hepatic encephalopathy were independent risk factors for short- and long-term mortality risk in ACLF patients (p < 0.05).Conclusions: Patients with DC-ACLF have a higher mortality rate, especially long-term mortality, compared to non-DC-ACLF patients. Therefore, DC should be included in the diagnostic criteria of APASL-ACLF and treated according to the ACLF management process.https://www.frontiersin.org/articles/10.3389/fmed.2021.750061/fullAsian Pacific Association for the Study of the Liver (APASL)acute-on-chronic liver failure (ACLF)diagnostic indicatormortalitydecompensated cirrhosis
spellingShingle Manman Xu
Manman Xu
Ming Kong
Ming Kong
Pengfei Yu
Pengfei Yu
Yingying Cao
Fang Liu
Bing Zhu
Yizhi Zhang
Yizhi Zhang
Wang Lu
Wang Lu
Huaibin Zou
Huaibin Zou
Shaoli You
Shaojie Xin
Zhongping Duan
Zhongping Duan
Tao Han
Yu Chen
Yu Chen
Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis
Frontiers in Medicine
Asian Pacific Association for the Study of the Liver (APASL)
acute-on-chronic liver failure (ACLF)
diagnostic indicator
mortality
decompensated cirrhosis
title Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis
title_full Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis
title_fullStr Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis
title_full_unstemmed Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis
title_short Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis
title_sort acute on chronic liver failure defined by asian pacific association for the study of the liver should include decompensated cirrhosis
topic Asian Pacific Association for the Study of the Liver (APASL)
acute-on-chronic liver failure (ACLF)
diagnostic indicator
mortality
decompensated cirrhosis
url https://www.frontiersin.org/articles/10.3389/fmed.2021.750061/full
work_keys_str_mv AT manmanxu acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT manmanxu acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT mingkong acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT mingkong acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT pengfeiyu acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT pengfeiyu acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT yingyingcao acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT fangliu acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT bingzhu acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT yizhizhang acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT yizhizhang acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT wanglu acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT wanglu acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT huaibinzou acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT huaibinzou acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT shaoliyou acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT shaojiexin acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT zhongpingduan acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT zhongpingduan acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT taohan acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT yuchen acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis
AT yuchen acuteonchronicliverfailuredefinedbyasianpacificassociationforthestudyofthelivershouldincludedecompensatedcirrhosis